BRIDION is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Medical Purchasing Solutions, Llc. The primary component is Sugammadex Sodium.
| Product ID | 71872-7187_9e3eb206-5c36-2c93-e053-2a95a90a9df0 |
| NDC | 71872-7187 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BRIDION |
| Generic Name | Sugammadex |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-12-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022225 |
| Labeler Name | Medical Purchasing Solutions, LLC |
| Substance Name | SUGAMMADEX SODIUM |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | gamma-Cyclodextrins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-12-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022225 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-12-16 |
| Ingredient | Strength |
|---|---|
| SUGAMMADEX SODIUM | 100 mg/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-5423 | BRIDION | sugammadex |
| 0006-5425 | BRIDION | sugammadex |
| 71872-7187 | BRIDION | sugammadex |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BRIDION 86588109 4979416 Live/Registered |
Merck Sharp & Dohme B.V. 2015-04-06 |
![]() BRIDION 86228696 4978527 Live/Registered |
Merck Sharp & Dohme B.V. 2014-03-21 |
![]() BRIDION 86228692 5223500 Live/Registered |
Merck Sharp & Dohme B.V. 2014-03-21 |
![]() BRIDION 85402383 not registered Dead/Abandoned |
MERCK SHARP & DOHME B.V. 2011-08-19 |
![]() BRIDION 79005765 3055628 Live/Registered |
MERCK SHARP & DOHME B.V. 2004-09-22 |